Attached files
| file | filename |
|---|---|
| 10-Q - 10-Q - Enumeral Biomedical Holdings, Inc. | s103860_10q.htm |
| EX-32.2 - EXHIBIT 32.2 - Enumeral Biomedical Holdings, Inc. | s103860_ex32-2.htm |
| EX-31.2 - EXHIBIT 31.2 - Enumeral Biomedical Holdings, Inc. | s103860_ex31-2.htm |
| EX-31.1 - EXHIBIT 31.1 - Enumeral Biomedical Holdings, Inc. | s103860_ex31-1.htm |
| EX-10.1 - EXHIBIT 10-1 - Enumeral Biomedical Holdings, Inc. | s103860_ex10-1.htm |
Exhibit 32.1
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Quarterly Report on Form 10-Q of Enumeral Biomedical Holdings, Inc. (the “Company”) for the quarter ended June 30, 2016 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), the undersigned, John J. Rydzewski, Executive Chairman of the Company, hereby certifies, pursuant to Rule 13a-14(b) and 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to his knowledge:
| (1) | The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and |
| (2) | The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. |
| Dated: August 12, 2016 | /s/ John J. Rydzewski |
| John J. Rydzewski | |
| Executive Chairman | |
| (Principal Executive Officer) |